Study of the effect of Anagliptin administration on the activity of glucagon after test meal loading
Phase of Trial: Phase II
Latest Information Update: 14 Jul 2017
At a glance
- Drugs Anagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 13 Jul 2017 According to UMIN, the date for data entry closure is 2018/02/28 , and the date for conclusion of data analysis is 2018/04/30.
- 13 Jul 2017 Planned End Date changed from 31 Jul 2017 to 31 Jan 2018.
- 10 Nov 2016 Planned End Date changed from 31 Dec 2016 to 31 Jul 2017.